Gene · 11274
Papers1,718
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,718
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of RNA modification in urological cancers: mechanisms and clinical potential. | Discov Oncol | 2023 | 38117350 | PubTator, text mining | PubMed |
| Case Report: ISG15 deficiency caused by novel variants in two families and effective treatment with Janus kinase inhibition. | Front Immunol | 2023 | 38115997 | PubTator, text mining | PubMed |
| Host-response transcriptional biomarkers accurately discriminate bacterial and viral infections of global relevance. | Sci Rep | 2023 | 38110534 | PubTator, text mining | PubMed |
| Reprogramming of tumor-associated macrophages via NEDD4-mediated CSF1R degradation by targeting USP18. | Cell Rep | 2023 | 38100351 | PubTator, text mining | PubMed |
| The two-stage molecular scenery of SARS-CoV-2 infection with implications to disease severity: An in-silico quest. | Front Immunol | 2023 | 38077337 | PubTator, text mining | PubMed |
| Tumour cells can escape antiproliferative pressure by interferon-β through immunoediting of interferon receptor expression. | Cancer Cell Int | 2023 | 38066598 | PubTator, text mining | PubMed |
| Identification of interferon-stimulated genes with modulated expression during hepatitis E virus infection in pig liver tissues and human HepaRG cells. | Front Immunol | 2023 | 38058490 | PubTator, text mining | PubMed |
| USP16 is an ISG15 cross-reactive deubiquitinase that targets pro-ISG15 and ISGylated proteins involved in metabolism. | Proc Natl Acad Sci U S A | 2023 | 38055744 | PubTator, text mining | PubMed |
| SARS-CoV-2 spike receptor-binding domain is internalized and promotes protein ISGylation in human induced pluripotent stem cell-derived cardiomyocytes. | Sci Rep | 2023 | 38049441 | PubTator, text mining | PubMed |
| Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy. | Acta Pharm Sin B | 2023 | 38045051 | PubTator, text mining | PubMed |
| Insights into the ISG15 transfer cascade by the UBE1L activating enzyme. | Nat Commun | 2023 | 38042859 | PubTator, text mining | PubMed |
| Dynamic RBM47 ISGylation confers broad immunoprotection against lung injury and tumorigenesis via TSC22D3 downregulation. | Cell Death Discov | 2023 | 38036512 | PubTator, text mining | PubMed |
| Chicken IFI6 inhibits avian reovirus replication and affects related innate immune signaling pathways. | Front Microbiol | 2023 | 38033564 | PubTator, text mining | PubMed |
| The effect of TLR3 priming conditions on MSC immunosuppressive properties. | Stem Cell Res Ther | 2023 | 38031182 | PubTator, text mining | PubMed |
| Mendelian susceptibility to mycobacterial diseases: State of the puzzle. | Qatar Med J | 2023 | 38025345 | PubTator, text mining | PubMed |
| Unraveling FOXO3a and USP18 Functions in Idiopathic Pulmonary Fibrosis through Single-Cell RNA Sequencing of Mouse and Human Lungs. | Glob Med Genet | 2023 | 38025194 | PubTator, text mining | PubMed |
| Variants of IFNL4 Gene in Amazonian and Northern Brazilian Populations. | Genes (Basel) | 2023 | 38003018 | PubTator, text mining | PubMed |
| Unwinding the SARS-CoV-2 Ribosomal Frameshifting Pseudoknot with LNA and G-Clamp-Modified Phosphorothioate Oligonucleotides Inhibits Viral Replication. | Biomolecules | 2023 | 38002341 | PubTator, text mining | PubMed |
| USP35 promotes HCC development by stabilizing ABHD17C and activating the PI3K/AKT signaling pathway. | Cell Death Discov | 2023 | 37993419 | PubTator, text mining | PubMed |
| Temporal patterns of gene expression in response to inoculation with a virulent Anaplasma phagocytophilum strain in sheep. | Sci Rep | 2023 | 37989861 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11274/papers?page=9